Literature DB >> 10469785

RSV immune globulin prophylaxis: is an ounce of prevention worth a pound of cure?

F W Moler1.   

Abstract

Mesh:

Substances:

Year:  1999        PMID: 10469785     DOI: 10.1542/peds.104.3.559

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


× No keyword cloud information.
  3 in total

1.  Hospitalisation for RSV infection in ex-preterm infants-implications for use of RSV immune globulin.

Authors:  M Thomas; A Bedford-Russell; M Sharland
Journal:  Arch Dis Child       Date:  2000-08       Impact factor: 3.791

Review 2.  Palivizumab for preterm infants. Is it worth it?

Authors:  N D Embleton; C Harkensee; M C Mckean
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-07       Impact factor: 5.747

3.  The clinical and health economic burden of respiratory syncytial virus disease among children under 2 years of age in a defined geographical area.

Authors:  S A Deshpande; V Northern
Journal:  Arch Dis Child       Date:  2003-12       Impact factor: 3.791

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.